HOLX News and Press, Hologic Inc. From 11/07/18

Hologic (NASDAQ: HOLX ): Q4 Non-GAAP EPS of $0.58 misses by $0.01 ; GAAP EPS of $0.18 misses by $0.17 . Revenue of $813.5M (+1.3% Y/Y) beats by $6.98M . Shares -1.8% . Press Release More news on: Hologic, Inc., Earnings news and commentary, Healthcare stocks news,

Hologic (NASDAQ: HOLX ) fiscal Q4 results ($M): Revenues: 813.5 (+1.3%); Breast Health: 322.2 (+7.1%). More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

– Revenue of $813.5 Million Grows 1.3%, 1.7% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.18, Non-GAAP Diluted EPS of $0.58 – – Company Expects Solid Revenue and EPS Growth in Fiscal 2019 – Hologic, Inc. (Nasdaq: HOLX) ann...

AAOI , ADT , ALB , ALRM , AMBC , ANGI , ANSS , ARNA , ATO , AVID , AVLR , AYX , BREW , CABO , CARG , CASA , CISN , CSGS , CSOD , CTRP , CVNA , CYBR , DVA , ECPG , EDIT , ENS , ENV , ET , EVC , EVRG , FARM , FG , FLO , FLS , FOSL , GDOT , GKOS , HK , HO...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Stifel 2018 Healthcare Conference in New York, NY on Tuesday, November 13 at 8 a.m. Eastern Time. The presentation will be webcast live and may be accessed through a link on the investors section of Hologic...

This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers’ 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers’ regulatory 13F Form filed on 10/30/2018. Please visit our Tracking Kahn Brothers Portfolio series t...